146 related articles for article (PubMed ID: 28661095)
1. Protein Concentration of Refractory Ascites in Cancer Patients is Reflected by the Presence and Severity of Peritoneal and Liver Metastasis.
Yamada Y; Yamaguchi A; Harada M; Kurasawa Y; Hara Y; Yamazaki D; Fujita S; Sonoda K; Masuda T; Yamada A; Ogawa Y; Hashimoto K; Kamijo Y
Ther Apher Dial; 2017 Jun; 21(3):263-269. PubMed ID: 28661095
[TBL] [Abstract][Full Text] [Related]
2. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological factors and long-term outcome comparing between lung and peritoneal metastasectomy after hepatectomy for hepatocellular carcinoma in a tertiary institution.
Kow AW; Kwon CH; Song S; Kim JM; Joh JW
Surgery; 2015 Apr; 157(4):645-53. PubMed ID: 25794626
[TBL] [Abstract][Full Text] [Related]
5. A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases.
Elias D; Faron M; Goéré D; Dumont F; Honoré C; Boige V; Malka D; Ducreux M
Ann Surg Oncol; 2014 Jun; 21(6):2052-8. PubMed ID: 24499829
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
Kozaki K; IInuma M; Takagi T; Fukuda T; Sanpei T; Terunuma Y; Yatabe Y; Akano K
Ther Apher Dial; 2016 Aug; 20(4):376-82. PubMed ID: 27523078
[TBL] [Abstract][Full Text] [Related]
8. Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites.
Yamada S; Hasegawa M; Nii N; Kato M; Ohashi A; Suzuki R; Komatsu M; Abe K; Hata Y; Takahashi K; Hayashi H; Koide S; Tsuboi N; Inaguma D; Yuzawa Y
Ther Apher Dial; 2019 Jun; 23(3):237-241. PubMed ID: 31025830
[TBL] [Abstract][Full Text] [Related]
9. [Cell-Free and Concentrated Ascites Reinfusion Therapy for Malignant Intractable Ascites from Colorectal Cancer].
Ohta K; Ikenaga M; Ueda M; Iwaki R; Kinoshita T; Mishima K; Shindo K; Chinen Y; Itakura H; Takayama T; Tsuda Y; Nakashima S; Adachi S; Endo S; Yamada T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1556-1558. PubMed ID: 29394700
[TBL] [Abstract][Full Text] [Related]
10. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
Yoshizawa M; Nakatsuji Y
Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
[TBL] [Abstract][Full Text] [Related]
15. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
[TBL] [Abstract][Full Text] [Related]
16. Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites.
Ito T; Hanafusa N; Fukui M; Yamamoto H; Watanabe Y; Noiri E; Iwase S; Miyagawa K; Fujita T; Nangaku M
Ther Apher Dial; 2014 Feb; 18(1):87-92. PubMed ID: 24499089
[TBL] [Abstract][Full Text] [Related]
17. Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer.
Yajima K; Kanda T; Ohashi M; Wakai T; Nakagawa S; Sasamoto R; Hatakeyama K
Am J Surg; 2006 Aug; 192(2):185-90. PubMed ID: 16860627
[TBL] [Abstract][Full Text] [Related]
18. A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.
Orimi S; Mizuno K; Narahara M; Umakosi H; Kaihara M; Hashimoto M
Ther Apher Dial; 2011 Aug; 15(4):411-4. PubMed ID: 21884478
[TBL] [Abstract][Full Text] [Related]
19. Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers.
Elias D; Faron M; Iuga BS; Honoré C; Dumont F; Bourgain JL; Dartigues P; Ducreux M; Goéré D
Ann Surg; 2015 Jan; 261(1):157-63. PubMed ID: 24509197
[TBL] [Abstract][Full Text] [Related]
20. Technical Performance and Clinical Effectiveness of Drop Type With Adjustable Concentrator-Cell Free and Concentrated Ascites Reinfusion Therapy.
Yamada Y; Harada M; Yamaguchi A; Kobayashi Y; Chino T; Minowa T; Kosuge T; Tsukada W; Hashimoto K; Kamijo Y
Artif Organs; 2017 Dec; 41(12):1135-1144. PubMed ID: 28589706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
